Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

LEXEO THERAPEUTICS INC (LXEO)

143 + Investors. Track Smart Money conviction in LXEO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +32
Streak
3Q ▲
Buyers last Q
72%

Smart Money Signals — LXEO

Based on 141 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added LXEO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
141 hedge funds hold LXEO right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +62% more funds vs a year ago

fund count last 6Q
+54 new funds entered over the past year (+62% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 72% buying

103 buying40 selling
Last quarter: 103 funds were net buyers (45 opened a brand new position + 58 added to an existing one). Only 40 were sellers (27 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter
Funds opening a new LXEO position: 17 → 16 → 27 → 45. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔄

Mostly new holders — 47% entered in last year

■ 17% conviction (2yr+) ■ 36% medium ■ 47% new
Only 24 funds (17%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.
💰

Value +131% but shares only +55% — price-driven

Value
+131%
Shares
+54%
Last quarter: the total dollar value of institutional holdings rose +131%, but actual share count only changed +55%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

27 → 17 → 16 → 27 → 45 new funds/Q
New funds entering each quarter: 17 → 16 → 27 → 45. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 57% of holders entered in last year

■ 7% veterans ■ 36% 1-2yr ■ 57% new
Of 143 current holders: 81 (57%) entered in the past year, only 10 (7%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
✅

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
26 of 141 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
5.0
out of 10
Moderate Exit Risk
Exit risk score 5.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — LXEO

In 2025 Q4, 103 hedge funds were net buyers of LXEO (45 opened a new position, 58 added to an existing one), while 40 reduced or exited (27 trimmed, 13 sold completely) — a 72% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 24% of total institutional value in LXEO is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +32 funds (more new holders than closures). Total institutional holders: 141.

Hedge Fund Ownership: LXEO

How many hedge funds hold LXEO — quarterly history vs. share price
Quarterly hedge fund ownership of LXEO vs. share price

Market Analysis: LXEO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: LXEO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

33 top-rated funds 2 high-conviction
Consensus
6.6
/ 10
breadth
×
Elite
2.1
/ 10
conviction
Hedge Fund Positioning: LXEO
2026 Q1 Stats Unlock in 4 days 143 + Investors

Track Smart Money conviction in LXEO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 143 110 30.0%
13F Shares 76M 49M 54.84%
Total Value $759M $328M 131.38%
New Positions 45 27 +18
Increased Positions 59 50 +9
Closed Positions 13 7 +6
Reduced Positions 30 15 +15
Total Calls 1 0 100%
Total Puts 1 1 -
PUT/CALL Ratio 1.0 0.0 Neutral

Statistics: LXEO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

143 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in LXEO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of LXEO — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CAXTON CORP 1.99% 13,943 $80K
2 Affinity Asset Advisors, LLC 1.50% 5,050,211 $29.0M
3 Spruce Street Capital LP 1.28% 928,593 $5.3M
4 Paradigm Biocapital Advisors LP 0.73% 6,184,134 $35.5M
5 Vestal Point Capital, LP 0.72% 4,475,000 $25.7M
6 Octagon Capital Advisors LP 0.70% 1,100,000 $6.3M
7 Frazier Life Sciences Management, L.P. 0.65% 4,424,725 $25.4M
8 DAFNA Capital Management LLC 0.49% 377,059 $2.2M
9 ORBIMED ADVISORS LLC 0.41% 3,602,450 $20.7M
10 683 Capital Management, LLC 0.36% 1,200,000 $6.9M
11 RA CAPITAL MANAGEMENT, L.P. 0.30% 5,000,000 $28.7M
12 Nantahala Capital Management, LLC 0.25% 1,200,000 $6.9M
13 Privium Fund Management B.V. 0.24% 205,000 $1.2M
14 Ikarian Capital, LLC 0.24% 513,011 $2.9M
15 SUVRETTA CAPITAL MANAGEMENT, LLC 0.18% 1,250,000 $7.2M
16 Avoro Capital Advisors LLC 0.11% 1,875,000 $10.8M
17 Woodline Partners LP 0.06% 2,750,532 $15.8M
18 Virtus Investment Advisers, LLC 0.04% 27,910 $160K
19 Burkehill Global Management, LP 0.04% 125,000 $718K
20 EntryPoint Capital, LLC 0.03% 16,560 $95K
21 Blackstone Inc. 0.02% 904,959 $5.2M
22 AXQ CAPITAL, LP 0.02% 26,119 $150K
23 Y-Intercept (Hong Kong) Ltd 0.02% 142,571 $818K
24 JANUS HENDERSON GROUP PLC 0.01% 4,976,429 $28.5M
25 Point72 Asset Management, L.P. 0.01% 1,680,449 $9.6M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — LEXEO THERAPEUTICS INC (LXEO)

What does the Smart Money Trend signal show for LXEO?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added LXEO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for LXEO?

More buyers than sellers — 72% buying: Last quarter: 103 funds were net buyers (45 opened a brand new position + 58 added to an existing one). Only 40 were sellers (27 trimmed + 13 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for LXEO holders?

Strong quality — 24% AUM from major funds: 26 of 141 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held LXEO?

Mostly new holders — 47% entered in last year: Only 24 funds (17%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.